Elevated calcium levels in the blood—a complication of kidney cancers known as hypercalcemia—may be successfully treated with ...

According to recent research, the drug, while still in its trial phases, has shown potential in inhibiting hormones that ...

In April 2021, dapagliflozin (Farxiga) received a new indication from the US Food and Drug Administration (FDA) for slowing progression of chronic kidney disease (CKD) in people without any other ...

A new Northwestern Medicine study has shed light on how a class of diabetes drugs may protect the kidneys—not just by ...

A popular drug given to more than a million people since 1993 to limit blood loss during heart surgery doubles a patient's risk of kidney failure and substantially increases the risk of a heart attack ...